Compliance With Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea Syndrome
NCT ID: NCT03776084
Last Updated: 2021-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
405 participants
OBSERVATIONAL
2019-06-01
2021-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Upper Airway Toning for Improve the Compliance of CPAP
NCT01936038
Continuous Positive Airway Pressure (CPAP) for Primary Care
NCT02459548
Follow-up of Patients With Obstructive Sleep Apnea in Primary Care.
NCT01918449
Comprehensive Management for the Treatment of Obstructive Sleep Apnea
NCT02482480
Validity of a Vibrating Postural Device for the Treatment of Positional Obstructive Sleep Apnea (Postural)
NCT03336515
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients SAHS with CPAP
Continuous Positive Airway Pressure treatment
Continuous Positive Airway Pressure
CPAP indication
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Continuous Positive Airway Pressure
CPAP indication
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Communication problems or inability to read and speak Spanish.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Corporacion Parc Tauli
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Montserrat Montaña
Principal Investigator, Clinical Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Montserrat Montaña, PHD
Role: PRINCIPAL_INVESTIGATOR
Corporacion Parc Tauli
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CorporacionPT
Sabadell, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018569
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.